forum semaglutide health Oral Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Semaglutide FAQ NDSU, Sanford Health launch GLP-1

In Zepbound , about 6%8% of people reported reactions, compared with 2% on placebo

Regular monitoring by a healthcare provider ensures safe use and helps clients achieve steady, long-term results

Macular complications: As Ozempic and other GLP-1 receptor agonists are associated with worsening diabetic retinopathy, they can also contribute to macular edema

Heise T, Mari A, DeVries JH et al (2022) Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial

If you are taking Semaglutide for either of these reasons, youll take it as directed by your healthcare provider since you are using it to manage a chronic condition

\Wound Healing & Tissue Repair: 2 faster epithelial barrier restoration